Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paliperidone ER in Adolescent Schizophrenia
NCT00518323Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Aug 2007
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of paliperidone in schizophrenia, sponsored by Johnson & Johnson. Started Aug 2007; status: completed.
02
Drugs
paliperidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00518323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00518323.